Latest Kaiser Health News Stories
At least 11 states are going to try to tax opioids despite pushback from pharmaceutical companies.
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue’s marketing of OxyContin.
Researchers combined the number of suicide deaths with those associated with drug overdoses in an effort to better grasp the overlap between these two public health epidemics.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?
One doctor in Kansas works to make sure every hospital in the state can provide the soft start, ideally with their mothers, that babies with neonatal abstinence syndrome need.
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about a spate of lawsuits involving the Affordable Care Act, as well as the latest in state and federal efforts regarding the Medicaid program for the poor.
A study published Thursday shows that doctors, dentists and other medical providers cut overall opioid dosages by nearly 10 percent after receiving notification of a death from a medical examiner and information on safe prescribing.
An approach known as Community Reinforcement and Family Training, or CRAFT, coaches families to deal with a loved one’s substance abuse with compassion.
Gabapentin, a medication approved to help patients with nerve pain or epilepsy, is being abused by people addicted to opioids to help prolong their high or stave off withdrawal from other drugs. Kaiser Health News reporter Carmen Heredia Rodriguez talks about the problem during a wide-ranging health discussion on the NPR program “On Point.”
Fentanyl and other painkillers marketed as safer than Purdue Pharma’s blockbuster drug left their own trail of overdose deaths.
States are passing laws that limit a doctor’s ability to prescribe opioids. Doctors and patients alike are wrestling with what that means in cases of chronic pain.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed — then walk it back?
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
KHN senior correspondent Fred Schulte talks about a cache of files detailing Purdue Pharma’s early OxyContin marketing plan.
The nation’s effort to combat this public health crisis could get caught in the crossfire of the Trump administration’s trade policies.